Literature DB >> 7282664

Categorization of etiology of failure to thrive.

C Homer, S Ludwig.   

Abstract

To develop predictors of organic vs nonorganic causes of failure to thrive, we performed a retrospective chart analysis of 82 hospitalized children. We evaluated predictors by using decision analysis. We estimated potential cost reduction that would have resulted from early categorization of these patients. Twenty-one cases had organic causes, 34 had nonorganic causes, and 19 had both organic and nonorganic causes. Physical examination proved to be a sensitive indicator of an organic component. The composite psychosocial and clinical history, together with the physical examination, accurately predicted the final category. The use of laboratory tests was primarily for confirmation. The use of these factors to identify purely nonorganic growth failure and an evaluation of such cases in an intermediate care facility could save almost $8-- per patient. In-depth psychosocial evaluation is important in all cases of failure to thrive.

Entities:  

Mesh:

Year:  1981        PMID: 7282664     DOI: 10.1001/archpedi.1981.02130330058019

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  5 in total

Review 1.  FAILURE TO THRIVE.

Authors:  V Venkateshwar; T S Raghu Raman
Journal:  Med J Armed Forces India       Date:  2017-06-10

Review 2.  Failure to thrive.

Authors:  H Marcovitch
Journal:  BMJ       Date:  1994-01-01

Review 3.  Non-organic failure to thrive: a reappraisal.

Authors:  D H Skuse
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

4.  Clinical Characteristics of Failure to Thrive in Infant and Toddler: Organic vs. Nonorganic.

Authors:  Suk Dong Yoo; Eun-Ha Hwang; Yeoun Joo Lee; Jae Hong Park
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31

5.  Failure to thrive in infant and toddlers: a practical flowchart-based approach in a hospital setting.

Authors:  Roberto Franceschi; Caterina Rizzardi; Evelina Maines; Alice Liguori; Massimo Soffiati; Gianluca Tornese
Journal:  Ital J Pediatr       Date:  2021-03-10       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.